Regenerative Medicine Market to Reach $37.27 Billion by 2031, Driven by the Growing Number of New Regenerative Medicine Approvals and Consistent Advancements in the Regenerative Medicine Space - Exclusive Report by Meticulous Research®

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom

- Sports Medicine Market is set to hit $10.59 billion by 2031, growing at an 8.2% CAGR from 2024. Discover trends and market dynamics driving this growth. 

Collagen and Gelatin Market - The collagen and gelatin market for regenerative medicine is expected to reach USD 709.9 million by 2022, at a CAGR of 8.5% during the forecast period of 2017 to 2022.

Radiation Dose Management Market - Radiation Dose Management Market is projected to reach $749.1 million by 2029, at a CAGR of 13.3%.

Molecular cytogenetics market -  Molecular cytogenetics market is expected to reach USD 2,266.4 million by 2022, at a CAGR of 11% during the forecast period of 2017 to 2022.

Next Generation Sequencing (NGS) Informatics Market - Next Generation Sequencing (NGS) Informatics Market is projected to reach $4.3 billion by 2030, at a CAGR of 15.4% from 2023 to 2030.

Regenerative Medicine Market Research Summary:

Particulars

Details

Number of Pages

248

Format

 PDF

Forecast Period

 2024-2031

Base Year

2023

CAGR

21.5 %

Estimated Market Size (Value)

 $37.27 billion by 2031

Segments Covered

 By Product

 Gene Therapy Cell TherapyStem Cell TherapyAutologous TherapyAllogenic TherapyPlatelet Rich Plasma TherapyCell-based Immunotherapy Tissue Engineering Products

By Application

 Cardiology Ophthalmology Oncology Neurology Immunology & Inflammation Musculoskeletal Dermatology Other Applications
(Note: Other applications majorly include wound care, orthopedics, and sports injuries.)

By End User

 Hospitals & Clinics Ambulatory Surgical Centers

Countries Covered

North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, Sweden, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa

Key Companies

Novartis AG (Switzerland), Biogen Inc. (U.S.), Kite Pharma, Inc. (U.S.), Spark Therapeutics, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Sarepta Therapeutics, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Amgen Inc. (U.S.), CORESTEMCHEMON Inc. (South Korea), Smith & Nephew plc (England), Vertex Pharmaceuticals Incorporated (U.S.), CSL Behring, LLC (U.S.), Janssen Global Services, LLC (U.S.), Medtronic plc (Ireland), AbbVie Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Ferring Pharmaceuticals A/S (Sweden), Pfizer Inc. (U.S.), bluebird bio Inc. (U.S.), and Vericel Corporation (U.S.).

Contact:
Mr. Khushal Bombe
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: [phone]
Europe: [phone]
APAC: [phone]
Email- [e-mail]
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/1100/regenerative-medicine-market

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/regenerative-medicine-market-to-reach-37-27-billion-by-2031--driven-by-the-growing-number-of-new-regenerative-medicine-approvals-and-consistent-advancements-in-the-regenerative-medicine-space---exclusive-report-by-meticulous-rese-302265644.html